| ApoA1: Mimetic peptide reverses adipocyte dysfunction in vivo and in vitro via an increase in hemeoxygenase (HO-1) and Wnt10b. | |
| | |
MedLine Citation:
|
PMID: 22306989 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Insulin resistance is a risk factor in the development of type 2 diabetes and is a major cause of atherosclerosis. Reduction in heme oxygenase (HO-1) has been shown to exacerbate vascular dysfunction and insulin resistance in obese mice and involves a decrease in adiponectin levels. Adiponectin is released from mesenchymal stem cell (MSC)-derived adipocytes, its levels are decreased in type 2 diabetes. We hypothesized that the apoA1 mimetic peptide, L-4F, will target the expression of the HO-1-adiponectin axis and reverse adipocyte dysfunction both in vivo and in vitro. The administration of L-4F [2 mg/Kg/daily (i.p.) for 4-week to 8-week-old obese (ob) mice restored adipocyte function, increased adiponectin release (p < 0.05) and decreased the levels of IL-1 and IL-6 (p < 0.05)]. These perturbations were associated with an increase in insulin sensitivity (p < 0.01 vs. untreated ob mice) and decreased glucose levels (309 + 42 vs. 201 + 8 mg/d after L-4F treatment). Treatment of both mesenchymal stem cell (MSC)-derived adipocytes with L-4F (50 μg/ml) increased adiponectin (p < 0.05), decreased IL-1 and IL-6 (p < 0.05) levels and increased MSC-derived adipocyte cell numbers by 50% in S phase (p < 0.05). MSC-derived adipocytes treated with L-4F increased WNT10b and decreased Peg 1/Mest. Inhibition of HO activity reversed the decrease in the adipogenic response gene, Peg 1/Mest. An increase of HO-1 expression by L-4F increased insulin-receptor phosphorylation. These findings support the hypothesis that L-4F increases early adipocyte markers, HO-1-adiponectin, WNT10b and decreases Peg1/Mest, negative regulators of adipocyte differentiation. |
| | |
Authors:
|
Ming Li; Luca Vanella; Donghyun Kim; Giuseppe Malfa; Lars Bellner; Tomoko Kawakami; Nader Abraham |
Related Documents
:
|
16722029 - Improvement of peritoneal ultrafiltration with peritoneal dialysis solution buffered wi... 22275939 - Type 2 diabetes mellitus in a nigerian child: a case report. 10682079 - Peritoneal dialysis prescriptions for diabetic patients. 11033179 - A microdialysis method for the in situ investigation of the action of large peptide mol... 6806189 - Morphologic changes of intralipid 20% liposomes in all-in-one solutions during prolonge... 14520019 - Influence of glucose in dialyzing fluid on purine concentrations in hemodialyzed patien... 2984069 - Sodium-potassium-atpase activity in the dorsal root ganglia of rats with streptozotocin... 14581149 - Translation of the recommendations for the diagnosis of diabetes mellitus into daily cl... 3293349 - Hypoglycaemia in childhood diabetes. i. clinical signs and hormonal counterregulation. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-2-15 |
Journal Detail:
|
Title: Cell cycle (Georgetown, Tex.) Volume: 11 ISSN: 1551-4005 ISO Abbreviation: - Publication Date: 2012 Feb |
Date Detail:
|
Created Date: 2012-2-6 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101137841 Medline TA: Cell Cycle Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Physiology & Pharmacology; University of Toledo College of Medicine; Toledo, OH USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Mimosine arrests the cell cycle prior to the onset of DNA replication by preventing the binding of h...
Next Document: MicroRNA-143 is critical regulator of cell cycle activity in stem cells with co-overexpression of Ak...